Q1 Earnings Forecast for Ayr Wellness Issued By Roth Capital

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Analysts at Roth Capital dropped their Q1 2025 EPS estimates for shares of Ayr Wellness in a report released on Monday, March 10th. Roth Capital analyst W. Kirk now expects that the company will post earnings of ($0.34) per share for the quarter, down from their prior estimate of ($0.32). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.31) per share. Roth Capital also issued estimates for Ayr Wellness’ Q2 2025 earnings at ($0.32) EPS, FY2025 earnings at ($1.26) EPS and FY2026 earnings at ($1.14) EPS.

Ayr Wellness (OTCMKTS:AYRWF) last posted its quarterly earnings data on Thursday, March 6th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.12). The company had revenue of $113.96 million for the quarter, compared to analyst estimates of $114.10 million. Ayr Wellness had a negative net margin of 48.17% and a negative return on equity of 25.30%.

Separately, Ventum Cap Mkts cut Ayr Wellness from a “strong-buy” rating to a “hold” rating in a research note on Friday, March 7th.

Ayr Wellness Stock Performance

Shares of OTCMKTS AYRWF opened at $0.16 on Thursday. Ayr Wellness has a 1 year low of $0.16 and a 1 year high of $3.46. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.58 and a current ratio of 1.59. The stock has a fifty day moving average price of $0.40 and a two-hundred day moving average price of $1.00. The firm has a market cap of $18.59 million, a P/E ratio of -0.07 and a beta of 1.70.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.